Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
EUDA Health Holdings Limited (EUDA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/05/2025: EUDA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -25.84% | Avg. Invested days 52 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 135.61M USD | Price to earnings Ratio - | 1Y Target Price 6 |
Price to earnings Ratio - | 1Y Target Price 6 | ||
Volume (30-day avg) 104279 | Beta -0.06 | 52 Weeks Range 1.64 - 6.30 | Updated Date 04/2/2025 |
52 Weeks Range 1.64 - 6.30 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.62 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -83.3% |
Management Effectiveness
Return on Assets (TTM) -86.3% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 137988041 | Price to Sales(TTM) 35.58 |
Enterprise Value 137988041 | Price to Sales(TTM) 35.58 | ||
Enterprise Value to Revenue 36.2 | Enterprise Value to EBITDA -25.9 | Shares Outstanding 37153000 | Shares Floating 18407957 |
Shares Outstanding 37153000 | Shares Floating 18407957 | ||
Percent Insiders 49.35 | Percent Institutions 2.49 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
EUDA Health Holdings Limited
Company Overview
History and Background
EUDA Health Holdings Limited is a healthcare company. Specific founding year and early milestones require further investigation into company filings. Their evolution likely involves growth through acquisitions and expansion of service offerings.
Core Business Areas
- Telehealth Services: Provision of remote healthcare consultations and monitoring through digital platforms.
- Specialty Pharmacy: Dispensing of specialized medications and providing pharmaceutical care services.
- Medical Device Sales: Distribution and sale of medical devices to healthcare providers and patients.
Leadership and Structure
Specific details on the leadership team and organizational structure would require direct access to EUDA Health Holdings Limited's website or regulatory filings.
Top Products and Market Share
Key Offerings
- Virtual Consultations: Offers remote consultations. Market share data unavailable, requires accessing EUDA Health Holdings Limited's financials. Competitors include Teladoc Health (TDOC), Amwell (AMWL).
- Specialty Drugs: Dispenses various specialty drugs. Market share data unavailable, requires accessing EUDA Health Holdings Limited's financials. Competitors include CVS Health (CVS), Walgreens Boots Alliance (WBA).
- Diagnostic Devices: Sells devices for home and clinical settings. Market share data unavailable, requires accessing EUDA Health Holdings Limited's financials. Competitors include Medtronic (MDT), Abbott Laboratories (ABT).
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth due to aging populations, technological advancements, and increasing demand for personalized care.
Positioning
EUDA Health Holdings Limited aims to integrate telehealth, pharmacy, and medical devices. Competitive advantage depends on the scale, integration capabilities, and technological innovation.
Total Addressable Market (TAM)
TAM for telehealth, specialty pharmacy, and medical devices is in the hundreds of billions. EUDA Health Holdings Limited's position depends on its ability to capture market share within these segments.
Upturn SWOT Analysis
Strengths
- Integrated Service Model
- Growing Telehealth Platform
- Specialty Pharmacy Expertise
Weaknesses
- Limited Brand Recognition
- Geographic Concentration
- Financial Resources Compared to Larger Competitors
Opportunities
- Partnerships with Healthcare Providers
- Expansion into New Geographic Markets
- Increased Adoption of Telehealth Services
Threats
- Regulatory Changes
- Competition from Established Players
- Economic Downturn Affecting Healthcare Spending
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- CVS
- WBA
- MDT
- ABT
Competitive Landscape
EUDA Health Holdings Limited faces competition from established players with greater resources. Its success depends on innovative solutions and strategic partnerships.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends unavailable without access to EUDA Health Holdings Limited's past financial performance.
Future Projections: Future growth projections depend on analyst estimates, which require access to financial analysis platforms.
Recent Initiatives: Recent strategic initiatives would be found in EUDA Health Holdings Limited's press releases and investor relations materials.
Summary
EUDA Health Holdings Limited operates in a growing healthcare market with a focus on integrating telehealth and specialty pharmacy services. The company faces stiff competition and needs to build brand recognition and scale operations to achieve sustainable growth. Strategic partnerships and technological innovation will be crucial for success. Financial performance data is needed to fully assess the company's strength and potential.
Similar Companies
ABT
Abbott Laboratories
ABT
Abbott Laboratories
AMWL
American Well Corp
AMWL
American Well Corp
CVS
CVS Health Corp
CVS
CVS Health Corp
MDT
Medtronic PLC
MDT
Medtronic PLC
TDOC
Teladoc Inc
TDOC
Teladoc Inc
WBA
Walgreens Boots Alliance Inc
WBA
Walgreens Boots Alliance Inc
Sources and Disclaimers
Data Sources:
- SEC Filings (when available)
- Company Website (when available)
- Industry Reports (when available)
- Analyst Reports (when available)
Disclaimers:
This analysis is based on publicly available information and limited financial data. It should not be considered financial advice. Accuracy of data cannot be fully guaranteed without access to complete financial statements.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About EUDA Health Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-12-14 | CEO & Executive Director Mr. Alfred Lim | ||
Sector Healthcare | Industry Health Information Services | Full time employees 106 | Website https://euda.com |
Full time employees 106 | Website https://euda.com | ||
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates in two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, and residential apartments, as well as condominiums. EUDA Health Holdings Limited is headquartered in Singapore.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.